Harmony Biosciences' Sales and Profits Have Soared. Why Hasn't Its Stock Followed?

Key Points Harmony's approved narcolepsy drug Wakix has been a huge financial success. Controversy and litigation surrounding Wakix have held back the stock. Longer-term worries about patent cliffs and Harmony's pipeline have also been bearish influences. 10 stocks we like better than Harmony Biosciences › Finding value stocks in today's market environment is challenging. To find them in the biotech stock arena is even more unusual. Harmony Biosciences (NASDAQ: HRMY) specializes in biotechnology ...